Improving postthyroidectomy care using a parathyroid hormone and calcium-based algorithm

What Was Tested

Researchers studied Parathyroid Hormone (PTH 1-84) in this observational study publication.

Since 2019, their institution has implemented a standardized postthyroidectomy protocol using parathyroid hormone (PTH) and calcium measurements to stratify hypocalcemia risk and guide calcium and alfacalcidol supplementation.

Who Took Part

The abstract describes 373 patients taking part.

The age groups tagged for this paper are adults, middle-aged adults and older adults, both men and women.

A retrospective observational cohort study was conducted at Radboud University Medical Center Nijmegen, including 373 adult patients who underwent total/completion thyroidectomy between January 2014 and April 2025.

Patients were assigned to either the postprotocol implementation cohort (PPC) (N = 154) or the historic cohort (N = 219), depending on whether surgery occurred after or before protocol implementation, and subsequently compared.

What Was Measured

Since 2019, their institution has implemented a standardized postthyroidectomy protocol using parathyroid hormone (PTH) and calcium measurements to stratify hypocalcemia risk and guide calcium and alfacalcidol supplementation.

PubMed files the paper under topics including Thyroidectomy, Parathyroid Hormone, Calcium, Hypoparathyroidism, Algorithms, Hypocalcemia and Postoperative Complications.

The authors tagged it with the keywords PTH and unscheduled referrals.

What This Means in Plain Language

This is an observational study of Parathyroid Hormone (PTH 1-84) in 373 patients.

With several hundred people or more, it is a fairly large study for this kind of research.

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2026 (European journal of endocrinology), a journal based in England.

More context: the Parathyroid Hormone (PTH 1-84) compound page, all human trials.